BioMarin Pharmaceutical, Inc. (BMRN)
56.92
+0.15
(+0.26%)
USD |
NASDAQ |
Jan 22, 13:32
BioMarin Pharmaceutical Research and Development Expense (TTM): 682.06M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amicus Therapeutics, Inc. | 142.29M |
| Gilead Sciences, Inc. | 5.734B |
| Merck & Co., Inc. | 14.26B |
| AbbVie, Inc. | 8.815B |
| Biogen, Inc. | 1.524B |